---
title: "Standardized Video-based Asynchronous Neurological Examination (VANE) Implemented Across 25 Sites"
id: "medrxiv-0-implementation-of-a-standardized-video-based-asynchronous-neurological"
canonical_url: "https://medichelpline.com/clinical-feed/medrxiv-0-implementation-of-a-standardized-video-based-asynchronous-neurological"
content_type: "clinical_feed_article"
specialty: "Neurology"
source_name: "medRxiv (Clinical Preprints)"
source_url: "https://www.medrxiv.org/content/10.64898/2026.07.15.26357456v1?rss=1"
published_at: "2026-07-17T12:00:00.000Z"
evidence_level: "Verified Feed"
license: "CC-BY-NC-4.0 / Informational Use"
---
# Standardized Video-based Asynchronous Neurological Examination (VANE) Implemented Across 25 Sites
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/medrxiv-0-implementation-of-a-standardized-video-based-asynchronous-neurological
- **Specialty:** [Neurology](https://medichelpline.com/clinical-feed/neurology.md)
- **Primary Source:** medRxiv (Clinical Preprints)
- **Source URL:** [Original Journal Publication](https://www.medrxiv.org/content/10.64898/2026.07.15.26357456v1?rss=1)
- **Published At:** 2026-07-17T12:00:00.000Z
- **Evidence Rating:** Verified Feed
## Executive GIST (TL;DR)
- The Diabetes Prevention Program Outcomes Study (DPPOS) added Alzheimer's disease (AD) and AD-related dementias (ADRD) phenotyping in 2022 using the NACC Uniform Data Set v3 (UDSv3), which includes a standardized neurological exam. - A video-based asynchronous neurological examination (DPPOS-VANE) was developed to align with UDSv3 and to detect common neurological diagnoses beyond dementia, such as diabetic cranial neuropathies, stroke, and parkinsonism. - DPPOS-VANE was iteratively designed by research clinicians and staff to be reproducible, conducted without direct examiner–participant contact, and independent of clinical skills of participant coordinators (PCs). - The exam was recorded on an iPad and assessed extraocular and facial movements, visual fields, speech, gross motor strength, pronator drift, praxis, and parkinsonism. - A 10-minute training video with stepwise scripts and English and Spanish instructions, plus site-specific performance review and staff certification, preceded central physician reading of videos. - Over two years, 1,286 DPPOS-VANE recordings led to 1,284 reviews: 1,204 (93%) adhered to the standard script, 41 (3%) had minor errors but remained usable, and 6 (0.4%) had major deviations; two recordings were unusable due to inaccessible video files. - Each exam took about 10–15 minutes. Across 25 sites, mean per-site completed exams was 51.4 (range 14–92). - The implementation engaged 55 research staff across 25 sites and three physician reviewers, demonstrating feasibility of a multisite standardized **video-based asynchronous neurological examination** using commonly available devices. - The study reports feasibility and potential as a paradigm for large epidemiological studies; details on diagnostic accuracy, inter-rater reliability metrics, and participant-level clinical outcomes were not reported in the source.
## Clinical Analysis & Structured Key Points
Skip to main content HOMESUBMITFAQBLOGALERTS / RSSRESOURCESABOUT Search for this keyword Advanced Search Follow this preprint Implementation of a standardized Video-based Asynchronous Neurological Examination (VANE) in a multi-center observational study of Alzheimer's disease (AD) and AD related dementias View ORCID Profile James M Noble, View ORCID Profile Neelesh K Nadkarni, View ORCID Profile Dianilka Martinez, View ORCID Profile Marinella Temprosa, View ORCID Profile Anna Bowers, View ORCID Profile Owen Carmichael, View ORCID Profile Lindsay Doherty, View ORCID Profile Gerardo J Febres, View ORCID Profile Danurys L Sanchez, View ORCID Profile Terry E Goldberg, View ORCID Profile Hanna Sherif, View ORCID Profile Vallabh Shah, View ORCID Profile Jose A Luchsinger, DPP Research Group doi: https://doi.org/10.64898/2026.07.15.26357456 This article is a preprint and has not been certified by peer review [what does this mean?]. It reports new medical research that has yet to be evaluated and so should not be used to guide clinical practice. AbstractInfo/HistoryMetrics Preview PDF Abstract Introduction: The Diabetes Prevention Program Outcomes Study (DPPOS) is an established cohort of aging persons with pre-diabetes and type 2 diabetes with 25 years of median follow-up. In 2022 DPPOS added Alzheimer's disease (AD), and AD related dementias (ADRD) phenotyping using the National Alzheimer's Coordinating Center (NACC) Uniform Data Set (UDSv3), which included a standardized neurological examination across 25 clinical sites, administered by clinical staff and interpreted centrally by clinicians. Methods: A DPPOS video-based asynchronous neurological examination (DPPOS-VANE) was developed iteratively through consensus from research clinicians and staff feedback to harmonize with UDSv3 to identify common neurological diagnoses aside from dementia including diabetic cranial neuropathies, stroke and parkinsonism. DPPOS-VANE was designed to be conducted without direct participant contact by the examiner, reproducible, and independent of clinical skills of PCs. An iPad camera recorded the video exam, comprised of assessments of extraocular and facial movements, visual fields, speech, gross motor strength, pronator drift, praxis and parkinsonism. A 10-minute training video demonstrated the examination step-by-step with scripts and instructions in English and Spanish. Site-specific performance review, feedback, and staff certification preceded central reading of video recordings by physicians. After two years of implementation, 1286 DPPOS-VANEs led to 1284 examination reviews. Of these, 1204 (93%) were completed by having the examiner follow the standard script. Overall, 1237 examinations (96%) were delivered as planned, 41 (3%) had minor errors but were still usable, and 6 (0.4%) had major deviations in exam technique; two additional recorded evaluations were not usable as recorded videos were inaccessible due to technical errors. Each examination was completed within 10-15 minutes. Each site on average completed 51.4 examinations (range 14-92). Discussion: Engaging 55 research staff across 25 sites and 3 physician-reviewers, this study is the first to demonstrate feasibility of a VANE as an efficient neurological examination model enabled by commonly used devices. Such a multisite standardized VANE represents a novel paradigm for large epidemiological studies. Competing Interest Statement JAL has been a consultant to Merck KGaA and Novo Nordisk, and receives a stipend from Wolters Kluwer as Editor of a journal. JMN receives a stipend from Springer as Editor of a journal, author royalties Oxford University Press, and editor royalties from Wolters-Kluwer. The other authors report no conflicts of interest. Clinical Protocols https://dppos.bsc.gwu.edu/web/dppos/dppos Author Declarations I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained. Yes The details of the IRB/oversight body that provided approval or exemption for the research described are given below: This study protocol was reviewed and approved by the Advarra single IRB (protocol Pro00047977) I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals. Yes I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance). Yes I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable. Yes FUNDER INFORMATION DECLARED National Institute of Diabetes and Digestive and Kidney Diseases, U01 DK048489, U01 DK048339, U01 DK048377, U01 DK048349, U01 DK048381, U01 DK048468, U01 DK048434, U01 DK048485, U01 DK048375, U01 DK048514, U01 DK048437, U01 DK048413 National Institute of Diabetes and Digestive and Kidney Diseases, U01 DK048411, U01 DK048406, U01 DK048380, U01 DK048397, U01 DK048412, U01 DK048404, U01 DK048387, U01 DK048407, U01 DK048443, U01 DK048400 National Institute on Aging, https://ror.org/049v75w11, 5 U19 AG078558 Copyright The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license. bioRxiv and medRxiv thank the following for their generous financial support: The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, The University of Edinburgh, University of Washington, and Vrije Universiteit Amsterdam. Donate to openRxiv Back to top Previous Next Posted July 17, 2026. Download PDF Print/Save Options Author Declarations Supplementary Material Data/Code Email Share Citation Tools Get QR code Reviews and Context 0 Comment 0 TRIP Peer Reviews 0 Community Reviews 0 Automated Services 0 Blogs/Media 0 Author Videos Subject Areas All Articles Addiction Medicine Allergy and Immunology Anesthesia Cardiovascular Medicine Dentistry and Oral Medicine Dermatology Emergency Medicine Endocrinology (including Diabetes Mellitus and Metabolic Disease) Epidemiology Forensic Medicine Gastroenterology Genetic and Genomic Medicine Geriatric Medicine Health Economics Health Informatics Health Policy Health Systems and Quality Improvement Hematology HIV/AIDS Infectious Diseases (except HIV/AIDS) Intensive Care and Critical Care Medicine Medical Education Medical Ethics Nephrology Neurology Nursing Nutrition Obstetrics and Gynecology Occupational and Environmental Health Oncology Ophthalmology Orthopedics Otolaryngology Pain Medicine Palliative Medicine Pathology Pediatrics Pharmacology and Therapeutics Primary Care Research Psychiatry and Clinical Psychology Public and Global Health Radiology and Imaging Rehabilitation Medicine and Physical Therapy Respiratory Medicine Rheumatology Sexual and Reproductive Health Sports Medicine Surgery Toxicology Transplantation Urology Evaluation/discussion of this paper x 0 0 0 0 0 0 We use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. Continue Find out more
## Related Clinical Research

- [2026 Stroke Rehabilitation Guideline: Start Early and Address Physical, Cognitive, and Mental Heal](https://medichelpline.com/clinical-feed/medical-news-today-0-stroke-rehab-guidelines-emphasize-early-support-for-physical-cognitive-and.md)
- [Hormone replacement therapy timing and menopause type linked to dementia risk in large UK study](https://medichelpline.com/clinical-feed/medical-news-today-1-menopause-type-and-hrt-timing-influence-dementia-risk-large-study-suggests.md)
- [Scalp acupuncture mechanisms regulating inflammation in vascular cognitive impairment](https://medichelpline.com/clinical-feed/pubmed-42621720.md) (DOI: 10.13702/j.1000-0607.20250874)
- [SniffCell: Cell-type-resolved somatic variant discovery from bulk long-read sequencing](https://medichelpline.com/clinical-feed/medrxiv-11-cell-type-resolved-somatic-variant-discovery-from-bulk-long-read-sequencing.md)
- [Pre-diagnostic 1-year prevalence of polypharmacy and PIMcog in Norwegian outpatients with MCI or d](https://medichelpline.com/clinical-feed/plos-one-14-one-year-pre-diagnostic-prevalence-and-associated-factors-of-polypharmacy-and.md)

## Navigation
- [← Back to Neurology Feed](https://medichelpline.com/clinical-feed/neurology.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.